Panbela Therapeutics Inc (PBLA)
0.44
0.00 (0.00%)
USD |
OTCM |
May 15, 15:37
Panbela Therapeutics Cash and Short Term Investments (Quarterly): 2.578M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 2.578M |
September 30, 2023 | 0.907M |
June 30, 2023 | 7.205M |
March 31, 2023 | 5.235M |
December 31, 2022 | 1.285M |
September 30, 2022 | 0.941M |
June 30, 2022 | 2.53M |
March 31, 2022 | 7.386M |
December 31, 2021 | 11.87M |
September 30, 2021 | 14.07M |
June 30, 2021 | 6.405M |
March 31, 2021 | 8.098M |
December 31, 2020 | 9.022M |
September 30, 2020 | 10.87M |
June 30, 2020 | 2.265M |
March 31, 2020 | 1.296M |
December 31, 2019 | 2.449M |
September 30, 2019 | 3.377M |
June 30, 2019 | 0.721M |
March 31, 2019 | 1.379M |
December 31, 2018 | 1.405M |
September 30, 2018 | 0.239M |
June 30, 2018 | 0.905M |
Date | Value |
---|---|
March 31, 2018 | 1.169M |
December 31, 2017 | 0.152M |
September 30, 2017 | 0.943M |
June 30, 2017 | 1.194M |
March 31, 2017 | 2.442M |
December 31, 2016 | 0.438M |
September 30, 2016 | 1.229M |
June 30, 2016 | 1.898M |
March 31, 2016 | 0.383M |
December 31, 2015 | 0.925M |
September 30, 2015 | 1.786M |
June 30, 2015 | 0.0648M |
March 31, 2015 | 0.2382M |
December 31, 2014 | 2.153M |
September 30, 2014 | 0.1316M |
June 30, 2014 | 0.1229M |
March 31, 2014 | 0.0711M |
December 31, 2013 | 0.0588M |
September 30, 2013 | 0.1038M |
June 30, 2013 | 0.0486M |
March 31, 2013 | 0.0544M |
December 31, 2012 | 0.1109M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
0.721M
Minimum
Jun 2019
14.07M
Maximum
Sep 2021
5.185M
Average
3.377M
Median
Sep 2019
Cash and Short Term Investments (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 1.823M |
Palatin Technologies Inc | 9.485M |
iBio Inc | 2.788M |
Theriva Biologics Inc | 18.26M |
Oragenics Inc | 3.484M |